跳至主要内容
临床试验/NCT05909111
NCT05909111招募中不适用

MR-Only Based Adaptive External Beam Radiation Therapy of Cervical Cancer on Ethos

Recherche clinique1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2022年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
15
试验地点
1
主要终点
Tumor regression assessment CBCT

研究概览

简要总结

Current management of patients treated with External Beam Radiation Therapy (EBRT) for cervical cancer with a classical Image-guided Radiation Therapy (IGRT) strategy involves a complex, not entirely satisfactory, treatment workflow. Indeed, in our institution, two workflows have been designed to take into account the inter-fraction motion of cervix and uterus : an Internal Target Volume (ITV)-based approach and a plan of the day strategy requiring both several planning-CT (Computed Tomography) acquisitions with variable bladder filling.The upcoming installation of a Varian Ethos therapy system in our institution will allow us to implement a less cumbersome online adaptive radiotherapy strategy (oART), which, by conforming to the daily anatomy, will enable a reduction in the Clinical Target Volume (CTV) to Planning Target Volume (PTV) margins leading to an expected reduction in dose delivered to organs at risk (OAR) .On the other hand, MR (Magnetic Resonance)-only treatment planning is playing an increasing role in radiotherapy, notably in the treatment of prostate cancer. MR-only workflows are known (a) to provide the most reliable delineation in soft tissues and (b) to decrease spatial uncertainties by suppressing the Magnetic Resonance Imaging (MRI)-CT co-registration. Regarding the management of cervical cancer, the importance of MRI is well established and its use becomes essential. Combining a MR-only workflow with an adaptative one on the Varian Ethos system, could lead to an improved management of patients treated for cervical cancer with an expected reduction in margins and volumes treated (thanks to MRI delineation and online adaptation) and therefore a reduction of OAR toxicity. Including regular multi-parametric MR imaging during and after the course of the treatment could also provide in the future an assessment of the treatment response. One of the important challenges in developing this specific workflow is to have a reliable synthetic CT (derived from MRI) to (a) provide electron or mass density for treatment planning calculations and (b) allow accurate online repositioning/deformation with Ethos Cone Beam Computed Tomography (CBCT). The other fundamental challenge is to provide a formal assessment of the clinical benefit of introducing MR-only simulation and planning in an oART workflow.

This project aims to demonstrate the feasibility of setting up an adaptive workflow on the ETHOS platform with the sole use of MR patient image.The project is divided into two parts. The first part consists in demonstrate the feasibility of the workflow on 15 patients with cervix cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age > 18 years old
  • Histologically proven cervical cancer (SCC, ADK ou adenous-SCC)
  • Patient for curative RTCT treatment
  • FIGO/TNM Stage IB2, IIA, IIB, IIIA, IIIB with or without lymph nodes involvement
  • No pregnancy
  • Informed consent dated and signed
  • Patient affiliated or beneficiary of a social security scheme
  • Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research).

排除标准

  • Metastatic disease
  • Contraindications to IRM examinations (claustrophobia, presence of metallic elements..)
  • Signes of active infection or serious health problems
  • Historic of abdominal or pelvis RT
  • Surgical history: partial or total hysterectomy

结局指标

主要结局

Tumor regression assessment CBCT

时间窗: 18 months

Volume Tumor regression on CBCT

Tumor regression assessment MRI

时间窗: 18 months

Volume Tumor regression on MRI

次要结局

未报告次要终点

研究者

发起方
Recherche clinique
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Recherche clinique

Principal Investigator

Institut Sainte Catherine

研究点 (1)

Loading locations...

相似试验